Kate Rosenbluth

What if electricity were a medicine?

Apply to Attend TEDMED 2018
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 14 - 16, 2018.
Apply Today!

Have a suggestion for The Hive?
Submit a Nomination Today

Share This Talk

About Kate Rosenbluth

Kate Rosenbluth is the CEO and Co-Founder of Cala Health. She is leading the team of innovators in a new class of therapy, neuroperipherals™, backed by the biggest leaders in technology and healthcare. Prior to Cala, she developed data-driven surgical, diagnostic and therapeutic technologies with Brainlab, Autonomic Technologies, Genentech, and UCSF. She has authored more than 50 patents and peer-reviewed publications and is a frequent speaker. She is a committed educator and has launched forward-looking programs including the Masters of Translational Medicine at UC Berkeley and the Accel Innovation Scholars at Stanford. She serves on the Strategy Group of the Center for Healthcare Innovation. She received a Mechanical Engineering Bachelors from Stanford University and a PhD in Bioengineering from UC Berkeley and UCSF, where she also completed a Postdoctoral Fellowship in Neurosurgery.  

Find out more

About This Idea

Neurological diseases affect millions of people—Parkinson’s alone affects 1 million Americans. As Founding CEO of Cala Health, Kate Rosenbluth has embraced a new class of electrical medicine, neuroperipheral therapy, to treat patients without drugs or surgery. Tune in to Kate’s 2017 Hive Talk to learn how Cala Health is combining innovations in three categories—medical devices, consumer electronics and individualized medicine—to help patients suffering from neurological diseases. 

Find out more

More Talks from the Hive

These talks are all a part of special session at TEDMED, called "Audacious" where we invite our innovators to take the stage and share the central idea they are working on, in short 2-minute talks. These talks are creatively grouped by 4 mini-segments, that serves as a creative link between each talk. To find out more visit The Hive page.